ezetimibe has been researched along with Muscle Disorders in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 18 (60.00) | 29.6817 |
2010's | 12 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hsiung, JT; Kleine, CE; Moradi, H; Park, C; Soohoo, M; Streja, DA; Streja, E | 1 |
Macchi, C; Magni, P; Morlotti, B; Ruscica, M; Sirtori, CR | 1 |
Graversen, CB; Larsen, ML; Schmidt, EB | 1 |
Cho, L; Colquhoun, D; Dent, R; Rocco, M; Rosenson, RS; Scott, R; Stroes, E; Sullivan, D; Wasserman, SM; Xue, A | 1 |
Ballantyne, CM; Catapano, A; Dent-Acosta, RE; Gouni-Berthold, I; Mancini, GB; Nissen, SE; Preiss, D; Rosenson, RS; Sattar, N; Scott, R; Stein, EA; Stroes, E; Thompson, PD; Wasserman, SM; Xue, A | 1 |
Fernandes, V; Pérez, A; Santos, MJ | 1 |
Bangalore, S; Hsue, PY; Waters, DD | 1 |
Ballantyne, CM; Brennan, DM; Bruckert, E; Ceška, R; Dent-Acosta, RE; Elliott, M; Gouni-Berthold, I; Lehman, SJ; Lepor, N; Nissen, SE; Preiss, D; Rosenson, RS; Sattar, N; Scott, R; Somaratne, R; Stein, EA; Stroes, E; Wasserman, SM | 1 |
Torjesen, I | 1 |
Tonstad, S | 1 |
Robinson, JG | 1 |
Brosteaux, C; Buclin, T; Kuntzer, T; Rodondi, N; Ruiz, J | 1 |
Lee, T | 1 |
Sacks, FM | 1 |
Fux, R; Gleiter, CH; Gundel, UF; Hartmann, R; Mörike, K | 1 |
Phillips, PS | 1 |
Cabello, A; Civeira-Murillo, F; Perez-Calvo, J | 1 |
McKenney, JM | 1 |
Poirier, P; Simard, C | 1 |
Havranek, JM; Phillips, PS; Warnke, GA; Wolfsen, AR | 1 |
Katz, U; Shoenfeld, Y; Szyper-Kravitz, M; Zimlichman, E | 1 |
Canora Lebrato, J; Frutos Pérez, B; Gutiérrez Gutiérrez, G; Zapatero Gaviria, A | 1 |
Ambrose, MS; Cote, H; DeNofrio, D; Duffy, GA; Patel, AR | 1 |
Shechter, M | 1 |
Abinader, EG | 1 |
Elisaf, MS; Florentin, M; Liberopoulos, EN | 1 |
Ballantyne, CM; Gimpelewicz, CR; Seper, C; Sirnes, PA; Stein, EA; Sussekov, A; Windler, E; Yigit, Z | 1 |
Bheemreddy, S; Foody, JM; Kashani, A; Mann, DL; Sallam, T; Wang, Y | 1 |
10 review(s) available for ezetimibe and Muscle Disorders
Article | Year |
---|---|
Precision Medicine and Personalized Management of Lipoprotein and Lipid Disorders in Chronic and End-Stage Kidney Disease.
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Dyslipidemias; Ezetimibe; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Kidney Failure, Chronic; Muscular Diseases; Niacin; PCSK9 Inhibitors; Pharmacogenomic Variants; Practice Guidelines as Topic; Precision Medicine; Renal Dialysis; Renal Insufficiency, Chronic | 2018 |
Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
Topics: Age Factors; Aged; Aged, 80 and over; Anticholesteremic Agents; Colesevelam Hydrochloride; Creatine Kinase; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Male; Muscular Diseases; Myalgia; Rhabdomyolysis; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sex Factors; Vitamin D Deficiency | 2015 |
[Statin intolerance].
Topics: Anticholesteremic Agents; Cardiovascular Diseases; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Risk Factors | 2015 |
Statin-related myotoxicity.
Topics: Clinical Trials as Topic; Comorbidity; Creatine Kinase; Cytochrome P-450 CYP3A; Dietary Supplements; Disease Management; Disease Susceptibility; Drug Interactions; Drug Substitution; Exercise; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Meta-Analysis as Topic; Muscular Diseases; Rhabdomyolysis; Risk Factors | 2016 |
[Statin intolerance].
Topics: Biological Products; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Muscular Diseases; PCSK9 Inhibitors; Risk Factors | 2017 |
LDL reduction: how low should we go and is it safe?
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Colesevelam Hydrochloride; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Ezetimibe; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Muscular Diseases; Niacin; Risk Factors; Stroke | 2008 |
[Statins and muscular side-effects].
Topics: Age Factors; Aged, 80 and over; Algorithms; Anticholesteremic Agents; Azetidines; Biopsy; Cardiovascular Diseases; Creatine Kinase; Ezetimibe; Female; Humans; Life Style; Male; Muscle, Skeletal; Muscular Diseases; Myositis; Pain; Primary Prevention; Randomized Controlled Trials as Topic; Retrospective Studies; Rhabdomyolysis; Secondary Prevention; Sex Factors; Ubiquinone | 2010 |
Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.
Topics: Allylamine; Anticholesteremic Agents; Atorvastatin; Azetidines; Cholesterol, LDL; Clinical Trials as Topic; Colesevelam Hydrochloride; Coronary Artery Disease; Drug Therapy, Combination; Ezetimibe; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Muscular Diseases; Niacin; Pyrimidines; Pyrroles; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome | 2005 |
Ezetimibe-associated adverse effects: what the clinician needs to know.
Topics: Anticholesteremic Agents; Azetidines; Chemical and Drug Induced Liver Injury; Drug Interactions; Ezetimibe; Humans; Hypercholesterolemia; Muscular Diseases; Treatment Outcome | 2008 |
Review of side-effect profile of combination ezetimibe and statin therapy in randomized clinical trials.
Topics: Anticholesteremic Agents; Azetidines; Drug Therapy, Combination; Ezetimibe; Gastrointestinal Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Incidence; Lipids; Muscular Diseases; Randomized Controlled Trials as Topic; Risk Factors | 2008 |
4 trial(s) available for ezetimibe and Muscle Disorders
Article | Year |
---|---|
Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Cholesterol, LDL; Double-Blind Method; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Muscular Diseases; PCSK9 Inhibitors; Young Adult | 2016 |
Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Apolipoprotein B-100; Biomarkers; Cholesterol, LDL; Clinical Protocols; Double-Blind Method; Ezetimibe; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Muscular Diseases; PCSK9 Inhibitors; Proprotein Convertase 9; Research Design; Time Factors; Treatment Outcome | 2016 |
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atorvastatin; Biomarkers; Cholesterol, LDL; Creatine Kinase; Cross-Over Studies; Double-Blind Method; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Muscular Diseases; Myalgia; Myositis; Rhabdomyolysis; Time Factors | 2016 |
Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
Topics: Anticholesteremic Agents; Azetidines; Cholesterol; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lipoproteins; Male; Middle Aged; Muscular Diseases; Treatment Outcome; Triglycerides | 2008 |
16 other study(ies) available for ezetimibe and Muscle Disorders
Article | Year |
---|---|
PCSK9 Inhibitors for Statin Intolerance?
Topics: Antibodies, Monoclonal; Anticholesteremic Agents; Cholesterol, LDL; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Muscular Diseases | 2016 |
Alternatives to statins in intolerant patients do lower cholesterol, study finds.
Topics: Antibodies, Monoclonal; Anticholesteremic Agents; Cholesterol, LDL; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Muscular Diseases | 2016 |
Ask the doctor. I have tried all of the statin drugs to lower my cholesterol, but each one has caused severe muscle pain. Are there any non-statin medications I could try using to lower my cholesterol?
Topics: Allylamine; Azetidines; Colesevelam Hydrochloride; Diet, Mediterranean; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Muscular Diseases; Niacin; Pain; Sitosterols | 2010 |
Low-density lipoprotein lowering therapy: an analysis of the options.
Topics: Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Coronary Disease; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Muscular Diseases; Simvastatin | 2002 |
Three new drugs for hyperlipidemia.
Topics: Azetidines; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Combinations; Ezetimibe; Humans; Hyperlipidemias; Hypolipidemic Agents; Intestinal Absorption; Lovastatin; Muscular Diseases; Niacin | 2003 |
Ezetimibe and statin-associated myopathy.
Topics: Adult; Azetidines; Creatine Kinase; Drug Interactions; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscular Diseases; Pain; Tendons | 2004 |
Ezetimibe and statin-associated myopathy.
Topics: Azetidines; Ezetimibe; Fatty Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Oxidation-Reduction | 2004 |
Worsening myopathy associated with ezetimibe in a patient with McArdle disease.
Topics: Anticholesteremic Agents; Azetidines; Ezetimibe; Glycogen Storage Disease Type V; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscular Diseases | 2005 |
Ezetimibe-associated myopathy in monotherapy and in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Topics: Adult; Anticholesteremic Agents; Azetidines; Creatine Kinase; Drug Interactions; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Muscle Weakness; Muscular Diseases; Pain | 2006 |
Monotherapy with ezetimibe causing myopathy.
Topics: Anticholesteremic Agents; Azetidines; Ezetimibe; Female; Humans; Middle Aged; Muscular Diseases | 2006 |
Intensive lipid-lowering therapy: obvious benefits, possible risks.
Topics: Aged, 80 and over; Azetidines; Coronary Disease; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Muscular Diseases | 2006 |
[Reversible myopathy due to ezetimibe].
Topics: Anticholesteremic Agents; Azetidines; Ezetimibe; Female; Humans; Middle Aged; Muscular Diseases; Remission, Spontaneous | 2007 |
Treatment of hypercholesterolemia with ezetimibe in cardiac transplant recipients.
Topics: Adult; Aged; Anticholesteremic Agents; Azetidines; Ezetimibe; Female; Heart Transplantation; Humans; Hypercholesterolemia; Lipoproteins; Lipoproteins, LDL; Male; Middle Aged; Muscular Diseases; Pain | 2007 |
Lipid-lowering therapy--benefits and risks.
Topics: Azetidines; Coronary Disease; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Muscular Diseases; Risk Factors | 2007 |
Lipid-lowering therapy--benefits and risks.
Topics: Aged, 80 and over; Azetidines; Coronary Disease; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Muscular Diseases; Risk Factors | 2007 |
I am a 74-year-old woman who walks every day and am not overweight. I had a stent put in two-and-a-half years ago. I have high blood pressure and cholesterol problems. I have tried all the statins and every one causes muscle pains. The pain gets so bad th
Topics: Aged; Allylamine; Anticholesteremic Agents; Azetidines; Colesevelam Hydrochloride; Diet; Exercise; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Pain; Sleep Wake Disorders | 2007 |